Regulated Press releases | EMARKET STORAGE - Teleborsa

EMARKET STORAGE - Teleborsa

11/11/2020 - 12:48

DiaSorin: North America growth drives up revenues and profitability in the first 9 months of 2020

11/11/2020 - 12:47

DiaSorin: la crescita del Nord America traina l’aumento di Ricavi e Redditività nei primi 9 mesi del 2020

10/30/2020 - 17:22

DiaSorin launches with CE mark the LIAISON® SARS-CoV-2 Ag, a new high-throughput antigen test for COVID-19 detection in symptomatic patients

10/26/2020 - 18:29

DiaSorin lancia con marcatura CE il LIAISON® SARS-CoV-2 Ag per la rilevazione dell’antigene SARS-CoV-2 in pazienti sintomatici

10/23/2020 - 19:41

Conclusion treasury shares buy-back plan

10/23/2020 - 19:38

Conclusione programma acquisto azioni proprie

10/23/2020 - 19:37

Weekly report treasury shares buy-back

10/23/2020 - 19:36

Informativa settimanale acquisto azioni proprie

10/16/2020 - 18:28

Weekly report treasury shares buy-back

10/16/2020 - 18:27

Informativa settimanale acquisto azioni proprie

10/01/2020 - 07:45

DiaSorin received FDA approval on 6 Hepatitis B tests, completing its Hepatitis offer in the US market

10/01/2020 - 07:43

DiaSorin ha ricevuto l’approvazione a commercializzare 6 test per l’epatite B dalla Food and Drug Administration americana

10/01/2020 - 07:32

DiaSorin’s LIAISON SARS-CoV-2 IgM test receives FDA Emergency Use Authorization for the U.S. market

10/01/2020 - 07:31

DiaSorin riceve l’approvazione ad uso di emergenza dalla Food and Drug Administration americana per il test LIAISON SARS-CoV-2 IgM negli Stati Uniti

09/23/2020 - 07:14

DiaSorin extends its current joint venture with the Chinese Government to open a new manufacturing and research site in China

09/23/2020 - 07:12

DiaSorin estende l’attuale joint-venture con il Governo cinese per l’apertura del nuovo impianto produttivo e di ricerca in Cina

09/16/2020 - 14:30

Update Annual Calendar of Corporate Events 2020

09/16/2020 - 14:29

Aggiornamento Calendario Annuale Eventi Societari 2020

09/16/2020 - 07:25

DiaSorin Simplexa™ COVID-19 Direct molecular test CE marked for saliva specimens

09/16/2020 - 07:22

DiaSorin ha posto la marcatura CE al proprio test Simplexa™ COVID-19 Direct per il suo utilizzo con campioni di saliva

09/08/2020 - 07:28

DiaSorin and MeMed partner to develop and commercialize novel host immune response based diagnostics solution

09/08/2020 - 07:27

DiaSorin e MeMed avviano una partnership strategica per lo sviluppo e la commercializzazione di una soluzione diagnostica

09/07/2020 - 18:18

DiaSorin receives FDA clearance for the SIMPLEXA™ Flu A/B & RSV Direct Gen II Assay

09/07/2020 - 18:14

DiaSorin riceve l’approvazione dalla Food And Drug Administration per commercializzare negli Stati Uniti il nuovo test SIMPLEXA FLU A/B & RSV Direct